Toxicity and survival associated with IV/IP chemotherapy following neoadjuvant chemotherapy and interval debulking surgery for epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Rios-Doria, E. [1 ]
Pezzillo, M. [1 ]
Ulm, M. A. [2 ]
Tillmanns, T. [2 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[2] Univ Tennessee, West Canc Ctr, Memphis, TN USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
269
引用
下载
收藏
页码：127 / 128
页数：2
相关论文
共 50 条
  • [1] Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
    Webber, Kate
    Friedlander, Michael
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 126 - 138
  • [2] Primary Chemotherapy for Inoperable Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without Delayed Debulking Surgery
    Saha, Antonio
    Varughese, Mohini
    Gallagher, Chris J.
    Orphanos, George
    Wilson, Peter
    Oram, David
    Jeyarajah, Arjun
    Reynolds, Karina
    Shepherd, John
    McCormack, Mary
    Olaitan, Adeola
    McDonald, Nicola
    Mould, Tim
    McNeish, Iain
    Ledermann, Jonathan A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (04) : 566 - 572
  • [3] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [4] Comparing overall survival in patients with epithelial ovarian, primary peritoneal or fallopian tube cancer who received chemotherapy alone versus neoadjuvant chemotherapy followed by delayed primary debulking
    Correa, R.
    Dunningan, S.
    Panzarella, T.
    Ferguson, S.
    Murphy, K.
    Mackay, H.
    Bernardini, M.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S66 - S66
  • [5] Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube, or primary peritoneal cancer: A Southwest Oncology Group study
    Tiersten, A.
    Liu, P.
    Smith, H.
    Wilczynski, S.
    Robinson, W.
    Markman, M.
    Alberts, D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S3 - S3
  • [6] Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review
    Zeeshanuddin Ahmad
    Amar Jain
    Nikhil Mehta
    Elroy Saldanha
    Dhruv Patel
    Sanjay M. Desai
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [7] Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review
    Ahmad, Zeeshanuddin
    Jain, Amar
    Mehta, Nikhil
    Saldanha, Elroy
    Patel, Dhruv
    Desai, Sanjay M.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (01)
  • [8] Comment on "Primary Chemotherapy for Inoperable Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without Delayed Debulking Surgery"
    Barton, Desmond P. J.
    Naik, Rajan
    Pomel, Christophe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (07) : 1104 - 1105
  • [9] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN FIGO STAGE III AND IV EPITHELIAL OVARIAN, TUBAL OR PERITONEAL CANCER
    Tzanis, A.
    Iavazzo, C. R.
    Hadjivasilis, A.
    Tsouvali, H.
    Antoniou, G.
    Antoniou, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A296 - A296
  • [10] Neoadjuvant chemotherapy with interval debulking surgery versus chemotherapy alone for advanced epithelial ovarian cancer
    Khouri, Olivia
    Fazzari, Melissa
    Katcher, Arielle
    Nevadunsky, Nicole
    Fife, Alexander
    Isani, Sara
    Smotkin, David
    Kuo, Dennis Yi-Shin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S209 - S210
12345